Related Experiment Video
Updated: Jul 8, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Treatment of sleep disorders in children
Janet C Lam1, Thornton B A Mason
1Janet C. Lam, MHS, MD University of Maryland, 737 West Lombard Street, First Floor, Baltimore, MD 21201, USA. jlam@peds.umaryland.edu.
Insights
Behavioral interventions and good sleep hygiene are key for managing pediatric sleep disorders in children and adolescents. Pharmacologic treatments are limited due to a lack of pediatric drug approvals.
Area of Science:
- Pediatric Sleep Medicine
- Child Development
- Behavioral Pediatrics
Background:
- Sleep disorders significantly impact children's growth and development.
- Behavioral interventions, including limit-setting and sleep hygiene, are primary management strategies.
- Adolescents require specific emphasis on good sleep hygiene practices for family-wide benefit.
Purpose of the Study:
- To review the current landscape of pediatric sleep disorder management.
- To highlight the importance of behavioral interventions and sleep hygiene.
- To discuss the challenges and status of pharmacologic treatments for pediatric sleep disorders.
Main Methods:
- Literature review of pediatric sleep disorder management strategies.
- Analysis of behavioral interventions, focusing on limit-setting and sleep hygiene.
- Examination of the regulatory status and clinical application of pharmacologic treatments in children.
Main Results:
- Behavioral interventions are the cornerstone of pediatric sleep disorder management.
- Consistent limit-setting is crucial for younger children, while sleep hygiene is vital for all ages.
- Limited US Food and Drug Administration-approved pharmacologic options exist for pediatric sleep disorders, with many treatments extrapolated from adult data.
Conclusions:
- Behavioral strategies and consistent sleep hygiene are essential for addressing pediatric sleep disorders.
- The scarcity of pediatric-specific pharmacologic treatments necessitates careful consideration and reliance on clinical experience and adult data extrapolation.
- Further pediatric clinical trials are needed to expand approved pharmacologic options for children's sleep issues.
Abstract:
Sleep disorders can have a significant impact on the growth and development of children. Behavioral intervention is the first step in the management of many sleep disorders. Limit-setting is particularly challenging in younger children but must be consistent. Good sleep hygiene practices must be emphasized to adolescents as well. Indeed, good sleep hygiene is an important intervention for the entire family. There is an emerging development of pharmacologic treatments for sleep disorders. However, as with most medications used for children, there is a paucity of drugs approved by the US Food and Drug Administration for sleep in children due to the limited number of pediatric clinical trials. As a result, most of what is prescribed has been extrapolated from adult studies and is based on clinical experience.
Related Concept Videos
Management of Insomnia
Nightmares and Night Terrors
Nightmares often...
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

